Drug Shortage Report for PRADAXA

Last updated on 2022-01-21 History
Report ID 152835
Drug Identification Number 02358808
Brand name PRADAXA
Common or Proper name PRADAXA 150MG
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Market Status MARKETED
Active Ingredient(s) DABIGATRAN ETEXILATE
Strength(s) 150MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 6x10
ATC code B01AE
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2022-01-15
Actual start date
Estimated end date 2022-02-04
Actual end date
Shortage status Actual shortage
Updated date 2022-01-21
Company comments Stock out resulted from overselling due to generic stock out and delays in receipt of replenishment order due to recent weather delays
Health Canada comments
Tier 3 Status No
Contact Address 5180 SOUTH SERVICE ROAD
BURLINGTON, ONTARIO
CANADA L7L 5H4
Company contact information 1800 263 2425

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2022-01-21 French Compare
v8 2022-01-21 English Compare
v7 2022-01-18 French Compare
v6 2022-01-18 English Compare
v5 2022-01-18 French Compare
v4 2022-01-18 English Compare
v3 2022-01-16 English Compare
v2 2022-01-14 French Compare
v1 2022-01-14 English Compare

Showing 1 to 9 of 9